Antares Pharma (ATRS) Misses Q3 EPS by 1c

November 9, 2016 8:04 AM EST
Get Alerts ATRS Hot Sheet
Price: $2.09 --0%

Today's EPS Names:
HBHC, CSX, SHLO, More
Trade ATRS Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Antares Pharma (NASDAQ: ATRS) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $11.15 million.

For earnings history and earnings-related data on Antares Pharma (ATRS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment